On May 26, 2023, the FDA announced it is requiring updates to the boxed warning and other information found on the label of prescription stimulants used in the treatment of attention deficit/hyperactivity disorder (ADHD), binge-eating disorder, and narcolepsy. In an effort to ensure important safety […]
Jun 1, 2023
By TruLaw